Dynavax Technologies Corporation (DVAX)

Exchange
NASDAQ
Symbol
DVAX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Country
USA

Stock price

At close: May 9, 2025

  • Open
    9.74
  • High
    9.88
  • Low
    9.38
  • Close
    9.41
  • Volume
    2,027,650

Financial ratios

Dec 31, 2024